Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 GBX | +2.86% | +1.05% | +15.20% |
Apr. 03 | Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director | CI |
Mar. 27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Chart calendar Allergy Therapeutics plc
Upcoming events on Allergy Therapeutics plc
Past events on Allergy Therapeutics plc
2024-03-27 03:00 am | Q2 2024 Earnings Release |
2024-03-08 06:00 am | Annual General Meeting |
2024-02-14 02:00 am | Q2 2024 Sales and Revenue Release - Trading Update |
2023-09-27 | Rights Issue: 6 new shares @ 0.01 GBP for 1 existing share |
2023-09-27 02:00 am | Q4 2023 Earnings Release |
2023-08-10 02:00 am | Q4 2023 Sales and Revenue Release - Trading Update |
2023-07-31 07:00 am | Shareholders Meeting |
2023-06-19 02:01 am | Q2 2023 Earnings Release |
2023-06-10 08:30 am | European Academy of Allergy and Clinical Immunology Congress |
2023-04-27 07:00 am | Shareholders Meeting |
2023-02-07 04:30 am | Annual General Meeting |
2023-01-20 02:00 am | Interim 2023 Sales and Revenue Release - Trading Update |
2022-10-17 06:00 am | Shareholders Meeting |
2022-10-03 05:00 am | FY 2022 Earnings Call - Second Call |
2022-09-29 07:00 am | FY 2022 Earnings Call |
2022-09-29 02:00 am | FY 2022 Earnings Release |
2022-09-12 09:00 am | H.C. Wainwright Global Investment Conference - Fireside Chat |
2022-07-15 02:00 am | FY 2022 Sales and Revenue Release - Trading Update |
2022-05-24 07:00 am | H.C. Wainwright Global Investment Conference |
2022-03-10 05:30 am | Investor Meeting |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 73,7 73,9 -0.25% | 78,2 78,2 0% | 84,3 84,3 0.03% | 72,8 74,2 -1.89% | 61,0 64,9 -6.08% |
EBITDA Million GBP | Released Forecast Spread | 6,48 2,02 220.84% | 12,2 7,60 60.78% | 8,16 5,17 57.88% | -8,08 -6,51 -24.13% | -31,9 -19,7 -61.94% |
EBIT Million GBP | Released Forecast Spread | 4,39 -3,49 225.82% | 8,31 3,90 112.87% | 4,03 1,59 153.16% | -12,2 -10,6 -15.45% | -36,1 -25,7 -40.58% |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 4,29 2,70 59% | 8,07 5,93 36.22% | 3,66 1,25 192.02% | -12,7 -11,1 -14.16% | -49,8 -26,1 -90.92% |
Net income Million GBP | Released Forecast Spread | 3,47 2,00 73.35% | 7,06 4,55 55.12% | 2,89 0,67 332.47% | -13,8 -12,0 -15.02% | -51,0 -26,9 -89.69% |
EPS GBP | Released Forecast Spread | 0,01 0,00 108% | 0,01 0,01 40% | 0,00 0,00 330% | -0,02 -0,02 -16.43% | -0,08 -0,02 -280.5% |
Announcement Date | 25/09/19 | 23/09/20 | 23/09/21 | 29/09/22 | 27/09/23 |
Quarterly results
Fiscal Period | June | 2020 S1 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 50,5 51,8 -2.56% | 24,1 24,1 -0.12% | 39,9 39,9 0% | 21,1 25,0 -15.8% | |
EBITDA Million GBP | Released Forecast Spread | -17,9 -10,9 -64.18% | -5,84 -5,00 -16.74% | -26,1 -14,8 -76.12% | ||
EBIT Million GBP | Released Forecast Spread | -19,7 -13,3 -47.83% | -7,96 -8,00 0.54% | -28,2 -17,8 -58.27% | ||
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -19,9 -13,5 -47.58% | -8,20 -8,20 0% | -41,6 -18,0 -131.27% | ||
Net income Million GBP | Released Forecast Spread | 6,67 | -20,4 -13,5 -51.46% | -8,51 -8,90 4.43% | -42,5 -18,0 -136.22% | |
EPS GBP | Released Forecast Spread | 0,02 0,02 -1.3% | 0,01 | -0,03 -0,02 -55.5% | -0,01 -0,01 -29% | -0,06 0,00 - |
Announcement Date | 04/03/20 | 03/03/22 | 29/09/22 | 19/06/23 | 27/09/23 |
Past sector events for Allergy Therapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AGY Stock
- Calendar Allergy Therapeutics plc